Nature Cell Biology 'Under Review': What Each Status Means

Nature Cell Biology operates the Nature Portfolio handling editor model. Nature's editorial team explicitly states: after initial checks are complete, the manuscript is assigned to a handling editor, who reads the paper, consults with the editorial team, and decides whether it should be sent for peer review. Editors decide whether to send a manuscript for peer review based on four explicit criteria: degree to which the work advances the field's understanding, soundness of conclusions, extent to which the evidence supports these conclusions, and wide relevance to the journal's readership. A handling editor at Nature Cell Biology typically reviews 30 to 50 manuscripts per quarter and spends 45 to 75 minutes on the initial read.

Nature Portfolio editorial culture at Nature Cell Biology is decisive: the 6-day immediate-rejection median means most rejections happen at the handling editor read in the first week. Papers that pass the handling editor stage have cleared the steepest filter at Nature Portfolio's specialty cell-biology title.

Before the paper reaches external reviewers, a Nature Portfolio handling editor at Nature Cell Biology evaluates whether the cell-biology mechanism warrants Nature Cell Biology's selective editorial slots. The 6-day immediate-rejection median reflects this fast desk-screen cadence. A desk rejection most often means the handling editor concluded that the work would fit better at a sister Nature Portfolio title (Nature Communications, Communications Biology) or that the wide-relevance criterion is not met.

The Nature Portfolio editorial office confirms files are complete: manuscript with figures embedded, supplementary information separate, reporting checklists where applicable (ARRIVE for animal work, MIQE for quantitative PCR), cover letter directed to the editor, conflict-of-interest declarations, ethics-statement documentation including IACUC approval for vertebrate animal work, and data-availability statement.

The handling editor reads the paper and evaluates cell-biology advance, methodological soundness, and wide relevance. Nature Portfolio's published guidance lists four explicit criteria; most rejections happen here within the 6-day immediate-rejection window.

In parallel with the handling editor's primary read, ambiguous-fit papers are discussed at the Nature Cell Biology editor meeting where peer handling editors at sister Nature Portfolio titles weigh in on whether the paper would fit better at Nature Cell Biology, Nature Communications, or Communications Biology. This editorial-team discussion runs alongside the desk-screen and adds 3 to 5 days to the timeline that is invisible to the author in the portal.

Nature Portfolio handling editors at Nature Cell Biology typically invite two to three external reviewers. The recruitment window can take 7 to 14 days because cell-biology reviewers with topic-matched expertise (e.g., live-cell imaging specialists, structural cell biology, organelle mechanism) are scarce.

Once reviewers agree to review, Nature Portfolio asks reviewers to complete their report within 1 to 2 weeks, a timeframe Nature Cell Biology describes as avoiding compromise of quality for speed. The 1.7-month first-review-round average reflects reviewer-extension reality across the typical recruitment-plus-review cycle. Reviewer reports for Nature Cell Biology tend to be thorough; 2500 to 5000 word reports are typical for primary research papers.

After both reports return, the handling editor synthesizes them. Total submission-to-acceptance averages about 5.0 months per community-reported data.

• Rejection within 1 to 3 days: Administrative issue or immediate scope mismatch.
• Rejection within 3 to 10 days: Handling editor desk rejection. Most rejections happen here per the 6-day immediate-rejection median.
• Still Under Review after 2 weeks: Strong signal. Paper passed the steepest Nature Portfolio filter.
• Still Under Review after 10 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry via the submission portal is appropriate.
• Status changes to "Reports Received": Reports are in; expect a decision within 2 to 3 weeks.

This is the most common anxiety we hear from Nature Cell Biology authors during the active editorial window. The honest answer: no, 6 weeks at Under Review puts you right at Nature Cell Biology's 1.7-month first-review-round average. Reports may already be in editorial synthesis with the handling editor preparing a recommendation. Most reviewer-driven delays come from reviewer-recruitment timing for cell-biology specialists rather than slow reviews. If the portal still says Under Review at the 9-week mark, the most likely explanation is that one of the assigned reviewers asked for an extension and the handling editor granted it. This is normal practice at Nature Portfolio even with the 1-2 week reviewer target.

What you should NOT do during the 6-to-9-week window is email the editorial office. Nature Portfolio handling editors at Nature Cell Biology are managing 40+ active papers; an inquiry at 6 weeks adds friction without accelerating the timeline.

If your Nature Cell Biology paper is rejected after review, the natural cascade depends on what the reviewers and handling editor cited:

Nature Communications is the most natural Nature Portfolio cascade because Nature Portfolio supports manuscript-transfer where the receiving editor can request reviewer reports from Nature Cell Biology, preserving substantial peer-review work. Nature Communications has a broader scope and an open-access publishing model. The transfer process takes 5 to 10 days.

Communications Biology is a Nature Portfolio open-access option for technically rigorous cell-biology papers where the wide-relevance criterion is narrower than Nature Cell Biology's bar.

Journal of Cell Biology (JCB) is a Rockefeller University Press cascade option for cell-biology papers with strong imaging or structural mechanism. RUP operates independently; reports do not transfer, but JCB editors may recognize Nature Portfolio reviewer reports informally.

Molecular Cell is a Cell Press cascade for molecular-mechanism papers where the broader cell-biology framing is secondary to the molecular-mechanism contribution.

Nature Portfolio asks reviewers at Nature Cell Biology to evaluate four things specifically. The table below maps each to actionable preparation.

Manusights review data from this journal family shows a specific risk pattern: in practice, we see Nature Cell Biology editors and reviewers specifically look for whether the manuscript has a cell-biology mechanism that can travel beyond one technique, model system, or subfield. Nature Portfolio's public criteria name degree of advance, soundness, supporting evidence, and wide relevance, but the status window is where authors should translate those criteria into the likely reviewer objections.

This guide tells you what Nature Cell Biology editors look for during the status window. Manusights has reviewed 50+ manuscripts targeting Nature Cell Biology or adjacent Nature Portfolio, Cell Press, and Rockefeller University Press cell-biology journals; full Manusights reviews include a 60-day money-back guarantee, and we do not train AI on customer manuscripts.

Wide-relevance framing is not visible enough

Nature Cell Biology reviewers may accept that the experiment is technically strong and still ask whether the result changes a broader cell-biology conversation. We see this risk in manuscripts framed around one organelle, one protein, one disease model, one cell line, or one imaging system without stating the wider principle. During Under Review, prepare a response sentence that connects the strongest figure to a broader mechanism such as membrane organization, trafficking, division, polarity, organelle dynamics, cytoskeletal regulation, or cell-state control. If that sentence is still narrow, run a Check whether your Nature Cell Biology framing is broad enough ->.

Image and method package is not audit-ready

Cell-biology reviewers often challenge methods before they challenge the claim. We frequently see requests for imaging acquisition parameters, quantification rules, segmentation details, replicate definitions, blinding, sample-size logic, antibody controls, rescue experiments, and raw-image accessibility. The strongest packages do not just add a methods paragraph. They connect each method detail to one conclusion it supports. If live-cell imaging, super-resolution microscopy, electron microscopy, organoid work, or animal imaging carries the manuscript, run a Check if your Nature Cell Biology image methods are audit-ready ->.

Nature Portfolio routing is not yet defensible

Nature Cell Biology, Nature Communications, Communications Biology, Journal of Cell Biology, and Molecular Cell can all be reasonable after a strong review cycle, but they imply different standards. Nature Cell Biology needs a specialty-journal advance with wide relevance. Nature Communications can fit broader multidisciplinary significance. JCB can fit classical cell-biology mechanism with imaging rigor. Molecular Cell can fit molecular mechanism with cell-biology consequences. If the manuscript could be moved without changing the framing, the current framing is probably too generic. Use a Check whether your Nature Portfolio routing plan is defensible -> to plan the decision tree.

Once the handling editor decides to send the paper for external review, Nature Cell Biology staff editors invite two reviewers (sometimes three for borderline-fit cell-biology papers) over 7 to 14 days because cell-biology subspecialty experts are scarce. Status updates flow through the Nature Cell Biology for-authors how-to-submit portal; editorial-office queries can reach cellbiol@us.nature.com per the Nature Cell Biology contact page.

This page was created from Nature Portfolio's public author guidance at nature.com/ncb/submission-guidelines/editorial-process, Nature Cell Biology editorial-process documentation including the 1-2 week reviewer target, Nature Portfolio peer-review guidance, community-reported transit data (6-day immediate rejection, 1.7-month first-review round, 5.0-month total handling), and Manusights pre-submission review experience with Nature Cell Biology-targeted manuscripts.

For the Nature Portfolio cell-biology landscape beyond Nature Cell Biology, see Nature Communications (broader scope with open-access), Communications Biology (Nature Portfolio open-access), Nature Reviews Molecular Cell Biology (review article focus), and sister Cell Press titles (Molecular Cell, Cell Reports). The choice across these titles depends on whether the central contribution is wide-relevance-cell-biology (Nature Cell Biology), broader-multidisciplinary (Nature Communications), open-access (Communications Biology), or review-article (Nature Reviews Molecular Cell Biology).

Reviewers at Nature Cell Biology typically draw from one cell-biology-mechanism expert and one broader-cell-biology specialist. Preparing a response template that addresses both perspectives accelerates revision rounds substantially.

For a pre-upload check of your manuscript against the Nature Cell Biology mechanism-plus-wide-relevance bar before submission, our Nature Cell Biology pre-submission diagnostic flags the orthogonal-validation gaps and narrow-framing weaknesses most likely to surface in reviewer reports.